Patients with haemophilia A with inhibitors in China: a national real‐world analysis and follow‐up
Sign Up to like & getrecommendations! Published in 2021 at "British Journal of Haematology"
DOI: 10.1111/bjh.17322
Abstract: The development of alloantibodies (inhibitors) against coagulation factor VIII (FVIII) is the most serious complication of FVIII replacement therapy in patients with haemophilia A (HA). We carried out a nationwide study focussing on patients with… read more here.
Keywords: real world; patients haemophilia; haemophilia inhibitors; china national ... See more keywords